Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
484 people get THOR articles and Market Currents by email alert.
Get email alerts on THOR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
PR Newswire (Fri, 8:00AM)
-
PR Newswire (May 14, 2013)
-
A Look Into Thoratec's Recent ResultsStockBaller • Mon, May 6 -
PR Newswire (May 2, 2013)
-
PR Newswire (Apr 22, 2013)
-
-
-
-
-
PR Newswire (Mar 19, 2013)
-
PR Newswire (Mar 18, 2013)
-
PR Newswire (Mar 11, 2013)
-
-
-
-
-
PR Newswire (Feb 11, 2013)
To learn more about Seeking Alpha Pro, click here.
-
A Look Into Thoratec's Recent ResultsStockBaller • Mon, May 6
-
-
Thoratec Stays One Beat Ahead Of The RestStock Doc • Mon, Dec 31, 2012 -
Thoratec: Getting Back InTraderMark • Tue, Sep 14, 2010 -
-
-
Thoratec's HeartWare Acquisition May Miss a BeatTraderMark • Tue, Feb 17, 2009
-
Thoratec Weathers the StormTraderMark • Mon, Dec 8, 2008
-
-
After Smashing Earnings, Thoratec Actually Guides UpTraderMark • Thu, Oct 30, 2008
-
-
Thoratec Acquires A-Vox For Cardiac Catheterization ExpertiseH.S. Ayoub • Thu, Oct 5, 2006
-
-
-
-
-
-
-
-
-
-
-
-
Analyst Scott Power Finds The Upside In Biotech Down UnderLife Sciences Report • Thu, Nov 8, 2012 -
-
-
2 Pharma Stocks With Potential Upside RewardsChandrasekhar Rajagopalan • Fri, Nov 2, 2012 -
-
2 Stocks Upgraded On October 3 To ConsiderJorge Aura • Fri, Oct 5, 2012 -
-
-
-
Thoratec's CEO Discusses Q2 2012 Results - Earnings Call TranscriptWed, Aug 1, 2012
-
Thoratec's CEO Discusses Q1 2012 Results - Earnings Call TranscriptTue, May 1, 2012
-
Thoratec's CEO Discusses Q4 2011 Results - Earnings Call TranscriptWed, Feb 8, 2012
-
Thoratec's CEO Discusses Q3 2011 Results - Earnings Call TranscriptTue, Nov 1, 2011
-
Thoratec's CEO Discusses Q2 2011 Results - Earnings Call TranscriptWed, Aug 3, 2011
-
Thoratec Corp. Q2 2009 Earnings Call TranscriptWed, Aug 5, 2009
-
Thoratec Corporation Q1 2009 Earnings Call TranscriptTue, May 12, 2009 • 1 Comment
-
Thoratec Corporation Q4 2008 Earnings Call TranscriptTue, Feb 17, 2009
-
Thoratec Corp. Q1 2008 Earnings Call TranscriptFri, May 30, 2008
-
Thoratec Corporation Q4 2007 Earnings Call TranscriptTue, Feb 5, 2008
-
PR Newswire (Fri, 8:00AM)
-
PR Newswire (May 14, 2013)
-
at MarketWatch.com (May 3, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (Apr 22, 2013)
-
PR Newswire (Mar 19, 2013)
-
PR Newswire (Mar 18, 2013)
-
at CNBC.com (Mar 13, 2013)
-
PR Newswire (Mar 11, 2013)
-
PR Newswire (Feb 11, 2013)
-
PR Newswire (Feb 5, 2013)
-
PR Newswire (Jan 28, 2013)
-
PR Newswire (Jan 7, 2013)
-
PR Newswire (Jan 3, 2013)
-
at MarketWatch.com (Dec 11, 2012)
-
PR Newswire (Dec 11, 2012)
-
PR Newswire (Dec 10, 2012)
-
PR Newswire (Nov 26, 2012)
-
at CNBC.com (Nov 21, 2012)
-
PR Newswire (Nov 21, 2012)
THOR vs. ETF Alternatives
Company Description
Thoratec Corporation is a world leader in mechanical circulatory support with a product portfolio to treat the full range of clinical needs for advanced heart failure patients. We develop, manufacture and market proprietary medical devices used for circulatory support. We also develop,... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, May 17, 12:06 PM Thoratec Corporation (THOR -1.5%) says it's received FDA approval to market the HeartMate II Pocket Controller, the small face of the HeartMate II LVAD System. The device controls the left ventricular assist device or LVAD, which is a kind of mechanical heart which is put inside a person's chest, to help the heart pump oxygen-rich blood throughout the body. Comment! [Healthcare, On the Move]
- Friday, May 17, 8:13 AM The FDA approves Thoratec's (THOR) HeartMate II pocket controller, a lighter, more compact version of the previous controller which pairs with the company's LVAD system. (PR) 1 Comment [Healthcare]
- Thursday, May 2, 4:22 PM Thoratec (THOR): Q1 EPS of $0.41 misses by $0.05. Revenue of $117.7M (-7% Y/Y) misses by $5.2M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, May 2, 12:10 AM Notable earnings after Thursday’s close: ACLS, ACTV, ADNC, AGNC, AIG, ALSK, AREX, ARNA, ATHN, BBG, BCOR, BERY, BRKR, CBI, CNQ, DNB, DOLE, DRIV, EGO, ELON, ELX, FBHS, FLR, FLT, GEOS, GHDX, GILD, GMED, GTY, HAIN, HI, HMA, HTGC, INVN, KOG, KRFT, LNKD, MKH, MTZ, MYL, NBIX, NFG, NILE, NSR, ONNN, OPEN, PKT, PWER, QLGC, SKUL, SPF, SPWR, SWN, TDC, THOR, TPX, TSYS, TTMI, WTW, WWWW, XL, ZAGG Comment! [Earnings]
- Wednesday, May 1, 5:35 PM Notable earnings after Thursday’s close: ACLS, ACTV, ADNC, AGNC, AIG, ALSK, AREX, ARNA, ATHN, BBG, BCOR, BERY, BRKR, CBI, CNQ, DNB, DOLE, DRIV, EGO, ELON, ELX, FBHS, FLR, FLT, GEOS, GHDX, GILD, GMED, GTY, HAIN, HI, HMA, HTGC, INVN, KOG, KRFT, LNKD, MKH, MTZ, MYL, NBIX, NFG, NILE, NSR, ONNN, OPEN, PKT, PWER, QLGC, SKUL, SPF, SPWR, SWN, TDC, THOR, TPX, TSYS, TTMI, WTW, WWWW, XL, ZAGG Comment! [Earnings]
-
Friday, March 8, 5:37 PM
After-hours top gainers, as of 5:15 p.m.: ELN +7%. THOR +3%. GAME +3%. TTI +2%. VELT +2%.
After-hours top losers: RMBS -4%. LKQ -4%. EZPW -4%. MBLX -3%. CYS -3%. Comment! [On the Move] - Wednesday, February 20, 3:43 PM Nabors Industries' (NBR) weak Q4 should pressure management to take stronger restructuring steps, Goldman's Waqar Syed says; shares are undervalued vs. peers, "a major change for a company that has historically traded at a premium." Of all 67 stocks on Goldman's Conviction Buy list, NBR is one of nine eyed for 30%-plus upside; the others are PANW, AAPL, HAL, TUMI, PRU, F, THOR, CBST. 1 Comment [Energy, Quick Ideas]
- Tuesday, February 5, 4:13 PM Thoratec (THOR): Q4 EPS of $0.38 in-line. Revenue of $128.5M (+17% Y/Y) beats by $9.41M. Shares +2.4% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Tuesday, February 5, 12:10 AM Notable earnings after Tuesday’s close: AFL, BNNY, BV, CBL, CERN, CHRW, CME, CMG, DIS, ENTR, EQR, EXPE, FISV, GLUU, GNW, GTAT, HAIN, HRZN, INFN, JIVE, KFN, KIM, LNC, MWA, MYGN, NLY, NSR, PACB, PNRA, SFLY, SIMG, SU, THOR, TRMB, TTWO, UNM, USNA, ZNGA 1 Comment [Earnings]
- Monday, February 4, 5:35 PM Notable earnings after Tuesday’s close: AFL, BNNY, BV, CBL, CERN, CHRW, CME, CMG, DIS, ENTR, EQR, EXPE, FISV, GLUU, GNW, GTAT, HAIN, HRZN, INFN, JIVE, KFN, KIM, LNC, MWA, MYGN, NLY, NSR, PACB, PNRA, SFLY, SIMG, SU, THOR, TRMB, TTWO, UNM, USNA, ZNGA Comment! [Earnings]
- Monday, December 10, 2012, 3:40 PM A group of Democratic Senators have signed a letter urging for a delay in implementing a tax on the medical device industry that is scheduled to go into effect January 1, saying the industry has received little guidance about how to comply with the tax, and is causing significant uncertainty and confusion. The Senators are requesting that a delay be included in the fiscal cliff bill Congress is currently negotiating. 2 Comments
- Wednesday, November 21, 2012, 12:28 PM Thoratec (THOR +5.3%) trades higher today after Wells Fargo ups the shares to Outperform and raises its valuation by roughly 20%. The move comes a day after the FDA approved rival HeartWare International's (HTWR -5.4%) heart-pumping device, and Wells notes that THOR's competing product showed a lower incidence of stroke in recent trials. Comment! [Healthcare, On the Move]
- Thursday, November 1, 2012, 5:25 PM Thoratec (THOR): Q3 EPS of $0.49 beats by $0.10. Revenue of $117.8M (+14.8% Y/Y) beats by $6M. Shares +3.8% AH. (PR) Comment! [Earnings, Healthcare, On the Move]
- Wednesday, August 1, 2012, 5:14 PM Thoratec (THOR): Q2 EPS of $0.45 in-line. Revenue of $118.6M (+6.7% Y/Y) misses by $2M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, May 1, 2012, 7:14 PM Thoratec (THOR) trades up after beating Q1 estimates across the board on stronger sales of its HeartMate and CentriMag products. The company also raises its FY12 guidance, now expecting an EPS of $1.62 - $1.72 per share on revenue between $452M - $467M. Shares +8.5% AH. Comment! [Healthcare, Earnings]
- Tuesday, May 1, 2012, 5:04 PM Thoratec (THOR): Q1 EPS of $0.51 beats by $0.10. Revenue of $126M (+27% Y/Y) beats by $15M. (PR) Comment! [Earnings]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.